Skye Bioscience, Inc.
SKYEPharmaceutical Preparations · SIC 2834 · CIK 0001516551
Revenue FY2025
—
Net Income
$(56.0M)
EPS (Basic)
$-1.41
Net Margin
—
ROE
-279.3%
Total Equity
$20.0M
Shares Out
35M
Skye Bioscience, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2012–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Platinum Investment Management
Platinum Investment Management
$0.2M
0.0%
—
Baker Bros. Advisors
Baker Bros. Advisors
$1.1M
0.0%
—
Insider Transactions
Reading stored insider transactions…